DISHMAN PHARMACEUTICALS & CHEMICALS LTD. - Outcome of Board Meeting
| < Back | |
| 28 May 2015 | |
| Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, has transacted the following:-<BR><BR>"1. The Board has deferred the Agenda relating to approval of the Audited financial statements for the year ended March 31, 2015 in view of disagreement with the statutory auditors with regard to reporting in the consolidated financial statements regarding accounting of employee pension benefits by the Swiss subsidiary CARBOGEN AMCIS, which is covering this liability by participating in an employee retirement benefit plan of a large and well respected insurance Company. As per Swiss GAAP, the said subsidiary has no liability for the same. However, the accounting treatment as per Indian GAAP is creating a technical anomaly and being material, the Board has felt it prudent to defer this Agenda item so that the matter can be appropriately addressed.<BR><BR>2. Consequently the agenda items relating to recommendation of dividend and other items related to audited financial result have also been deferred". | |
| View all announcements for DISHMAN PHARMACEUTICALS & CHEMICALS LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback